Scientist and leader @rhoworld working on neuroscience and NIH studies. Opinions are my own. NIAID U01 PI.
Joined January 2008
- Tweets 4,703
- Following 818
- Followers 901
- Likes 2,333
628 Photos and videos
7 Mar 2024
The logo for my conference reminds me of MST3K. Trying to unsee this.
216
16 Feb 2024
I'm very excited that the OUtMATCH study, run by my team under awards from NIAID, was central to the FDA's approval of omalizumab to treat food allergy. This is a huge win for everyone worried about accidental exposures to allergens. fda.gov/news-events/press-an…
1
1
2
515
16 Feb 2024
This study was super complex and so much credit is due the operational team who got it done. There are 3 complex stages, multiple randomizations, and 95 secondary outcomes. classic.clinicaltrials.gov/c…
1
1
182
2 Jan 2024
Great interview with Karl Kieburtz on the promise of CVN424 to provide relief and hope to people with Parkinson's. youtube.com/watch?v=0CBl0IpV…
1
1
114
Peter Schmidt retweeted
21 Dec 2023
Only three applications submitted so far! If you live in Ward 3, please consider applying by 5pm today!!
1
3
7
1,263
21 Dec 2023
People who are interested in this innovative Parkinson's trial should check out the trial website: ascendclinicaltrial.com/
It lists the inclusion criteria and a pre-screener.
17 Nov 2023
A @DavisPhinneyFND blog on a new trial just posted. Of the two neural circuits we focus on in Parkinson's, the "direct" and "indirect" pathways, most drugs target the direct pathway. DBS targets the indirect. This drug could also help the indirect pathway. davisphinneyfoundation.org/c…
107
17 Nov 2023
A @DavisPhinneyFND blog on a new trial just posted. Of the two neural circuits we focus on in Parkinson's, the "direct" and "indirect" pathways, most drugs target the direct pathway. DBS targets the indirect. This drug could also help the indirect pathway. davisphinneyfoundation.org/c…
1
1
282
20 Nov 2023
This trial is currently recruiting! It would be great to get participants in Detroit, Scottsdale, Southern Illinois, Memphis, Boulder, and several sites across south Florida. Check the site listing here: clinicaltrials.gov/study/NCT…
1
69
16 Sep 2023
If you are interested in Parkinson’s, @MichaelOkun’s interview here with @SoaniaMathur shows why his perspective is the best there is in the field. Great for scientists, clinicians and patients alike. davisphinneyfoundation.org/p…
2
225
4 Sep 2023
We need better, more straightforward guidance on diagnosis and management, too. New drug formulations could help.
4 Sep 2023
We as a community need to reach and train more general medical professionals to help with the growing number of movement disorders patients.
Share this across your networks: loom.ly/uN98F3g
1
153
31 Aug 2023
Very proud of @HuntingtonSG! Two HSG trials were recognized in the #MDSCongress highlights session. One of the drugs was approved.
1
9
447
18 Jul 2023
Scandinavian metalwork changed battle wounds: a human skull with sword or axe wound, from the Viking era. National Museum of Ireland - Archaeology, Dublin. Undated. Cc @OGdukeneurosurg
1
198
14 Jul 2023
Great #wpc2023 conference with all my Parkinson’s friends. I visited with @ParkinsonDotOrg’s leading light in professional education, Denise, and Gila Bronner, sex therapist extraordinaire.
1
7
677
4 Jul 2023
I just noticed from a photo of the Titan submersible that they appear to have screwed some screens and lights directly into the pressure hull. The epoxy used in carbon fiber is usually brittle and this is a very bad idea. (1)
2
1
242
4 Jul 2023
In fracture mechanics, we’ve learned that the stresses in a situation like this can grow without limit - until relieved by structural failure. You can’t just put a screw into a carbon fiber bicycle, for example, for the same reason. But this is worse. (2)
1
98
Peter Schmidt retweeted
25 Jun 2023
Basic neurotransmitters
Source health center
3
39
142
16,216
16 Jun 2023
ICH, where regulatory and industry stakeholders harmonize worldwide drug regulation - important for promoting access - embraces use of "participant" instead of "subject" in trials. Their ICH E8(R1) document, with guidelines for clinical trials, has been adopted by the FDA.
1
142